Poland· PL-100061607
Jodek sodu Na 131I, roztwór do wstrzykiwań
A v09fx03, v10xa01 product containing natrii iodidum (131i) solutio iniectablis, registered in Poland by Narodowe Centrum Badań Jądrowych.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Natrii iodidum (131I) Solutio Iniectablis
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09FX03, V10XA01
- ATC class
- V09FX03, V10XA01
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990327119
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aedb01b7-88e2-4cb7-acb4-b4c66b66faf5 GET /v1/drugs/aedb01b7-88e2-4cb7-acb4-b4c66b66faf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "37-740 Mbq/ml",
"packaging": "05909990327119 ¦ Lz ¦ 1504\n1 fiol.",
"substance": "Beznośnikowy Jodek-131I sodu 37-740 MBq/ml",
"common_name": "Natrii iodidum (131I) Solutio Iniectablis",
"pl_product_id": "100061607",
"pozwolenie_nr": "03271",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about natrii iodidum (131i) solutio iniectablis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.